Vaxart (NASDAQ:VXRT) stock jumped 37.9% premarket after the company reported positive early-stage data for its ...

Vaxart's (NASDAQ:VXRT) shares rose following the positive results from an early stage trial of its new oral pill vaccine for ...

USA-based biotech Vaxart has reported positive top-line results from a Phase I trial comparing its second-generation oral ...

SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its ...

Investors may submit written questions in advance of the conference call to ir@vaxart.com. A replay of the webcast will be available on the Company’s website at www.vaxart.com following the ...

Real-time index price for Nasdaq 100 [TR] (XNDX), along with buy or sell indicators, analysis, charts, historical performance ...

Data show that Vaxart’s HPV vaccine constructs stimulate specific T cell immune responses, reduce tumor size, and increase survival in an animal model of human papillomavirus (HPV)-related ...

Vaxart Inc (NASDAQ:VXRT) shares are trading higher in Monday’s after-hours session after the company provided business and cash runway updates. What Happened: Vaxart, a clinical-stage ...

California biotech company Vaxart, which is working on a Covid-19 vaccine, is under federal investigation and is being sued by a number of investors for allegedly exaggerating its involvement in ...

Vaxart is now being investigated by the government and sued by its investors. Vaxart, a small California biotechnology working on a COVID-19 vaccine, is now being investigated by the government ...